Table 1

 Baseline demographic data and duration of follow up in all the patients with severe systemic sclerosis (SSc) treated by autologous peripheral blood stem cell (PBSC) or bone marrow (n = 2) transplantation with at least 6 months’ follow up and reported by centres from nine European countries to the EBMT/EULAR registry between August 1996 and August 2002

Demographic characteristicCohort data
Total patient number57
Age (years), median (range)40 (9.1–68.7)
Sex (F/M)47/10
Disease pattern50 diffuse/4 limited/3 not specified
Disease duration (months), median (range)36 (2.2–159.4)
Duration of follow up (months), median (range)20 (0.3–81.1)